Latest News

CROI 2026 showcased breakthroughs alongside funding crisis disrupting global and domestic HIV services.

CANN marks 30th anniversary with expanded partnerships and cross-condition advocacy evolution.

CDC progress data on STI and overdose prevention initiatives shows mixed results.

Data gaps in HIV surveillance for transgender people and policy implications.

Grindr's at-home STI testing kits address barriers to sexual health testing.

First year results of Together TakeMeHome HIV self-testing distribution program.

Major HIV research breakthroughs from CROI 2024: long-acting treatments and prevention advances.

Transgender communities face elevated HIV risk; stigma and discrimination undermine prevention.

Congenital syphilis cases tripled since 2017; integrated response including testing and education needed.

CDC data shows declining health ratings, increased mental health needs, and housing insecurity among PLWH.

CANN survey assesses HIV advocacy organizations' capacity to hire and support transgender staff.

New MPOX clusters signal resurgence; insufficient vaccine coverage in marginalized communities.

Nashville Fireside Chat: state funding cuts, 340B reform, and HIV criminalization law changes.

Transgender men underrepresented in HIV data despite elevated risk; inclusive data collection needed.

STI surveillance report shows rising syphilis and congenital syphilis amid workforce shortages.

Timeline of 2022 MPV outbreak: racial disparities in vaccination and treatment access persist.

MPV becoming endemic in MSM communities; vaccine distribution disparities impede response.

HIV-MPV co-infection rates between 28-51% indicate need for targeted interventions and provider education.

US Trans Survey provides critical data on transgender healthcare, discrimination, and social determinants.

State-level MPV surveillance: Black Americans overrepresented in Southern states amid reporting gaps.